Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study
Publication
, Conference
Voorhees, PM; Gasparetto, C; Richards, KL; Garcia, R; Strader, JS; Ferraro, M; MacLean, J; Winans, D; Moore, DT; Dodd, A; Foster, MC; Shea, TC ...
Published in: BLOOD
November 20, 2009
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 20, 2009
Volume
114
Issue
22
Start / End Page
129 / 130
Location
New Orleans, LA
Publisher
AMER SOC HEMATOLOGY
Conference Name
51st Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Voorhees, P. M., Gasparetto, C., Richards, K. L., Garcia, R., Strader, J. S., Ferraro, M., … Hurd, D. D. (2009). Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study. In BLOOD (Vol. 114, pp. 129–130). New Orleans, LA: AMER SOC HEMATOLOGY.
Voorhees, Peter M., Cristina Gasparetto, Kristy L. Richards, Reynaldo Garcia, John S. Strader, Madlyn Ferraro, Jennifer MacLean, et al. “Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.” In BLOOD, 114:129–30. AMER SOC HEMATOLOGY, 2009.
Voorhees PM, Gasparetto C, Richards KL, Garcia R, Strader JS, Ferraro M, et al. Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study. In: BLOOD. AMER SOC HEMATOLOGY; 2009. p. 129–30.
Voorhees, Peter M., et al. “Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.” BLOOD, vol. 114, no. 22, AMER SOC HEMATOLOGY, 2009, pp. 129–30.
Voorhees PM, Gasparetto C, Richards KL, Garcia R, Strader JS, Ferraro M, MacLean J, Winans D, Moore DT, Dodd A, Foster MC, Gabriel DA, Shea TC, Serody J, van Deventer HW, Rizvi S, Orlowski RZ, Hurd DD. Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study. BLOOD. AMER SOC HEMATOLOGY; 2009. p. 129–130.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 20, 2009
Volume
114
Issue
22
Start / End Page
129 / 130
Location
New Orleans, LA
Publisher
AMER SOC HEMATOLOGY
Conference Name
51st Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology